Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1130598 · TRAW

Traws Pharma, Inc.

Filing with the SEC SEC-reporting company Newtown, PA Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • Exchange listing at riskOn Jul 31, 2026 the company disclosed a notice from its exchange (Item 3.01). Exchanges usually give a period to regain compliance before delisting.
  • Stockholders’ deficitAt the end of 2025 total liabilities exceeded total assets: stockholders’ equity was −$629K (XBRL data filed with the SEC).
  • Private capital raiseOn Nov 5, 2026 the company filed Form D: $50M offered · Biotechnology. A Form D is a notice of an exempt offering, not an SEC approval; the figures are the issuer’s own.

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Revenue$2.8M$226K
Net income (loss)$9.2M−$167M
Total assets$10.6M$25M
Total liabilities$11.2M$56.6M
Stockholders’ equity−$629K−$31.6M
Cash and equivalents$3.8M$21.3M

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
Traws Pharma, Inc.
Formerly: Onconova Therapeutics, Inc.
CIK
0001130598
Tickers
TRAW
Kind of filer
SEC-reporting company
Non-accelerated filer; Smaller reporting company
Legal form
Corporation
Status
Filing with the SEC
State of incorporation
Delaware
Business address
Newtown, Pennsylvania
Industry (SIC)
2834 · Pharmaceutical preparations
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
10-K for the period ended Dec 31, 2025
Last quarterly report
10-Q for the quarter ended Jun 30, 2026
Latest exempt offering
$50M offered
Revenue range stated: Decline to Disclose
Bankruptcy reported
Not in our data
Last edition event
Nov 5, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Private raise (Form D): $50M offered · Biotechnology
    Form D · items 06B · filed Nov 5, 2026 · filing · edition of Nov 5, 2026
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Oct 26, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Aug 14, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Aug 14, 2026 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Jul 31, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.07, 9.01 · filed Jul 9, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed May 15, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed May 15, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Apr 15, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2025
    Form 10-K · filed Apr 15, 2026 · filing
  • Late annual report notice: Annual report (10-K) will be late
    Form NT 10-K · filed Mar 31, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Dec 16, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.07, 9.01 · filed Nov 28, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Nov 13, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 13, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Oct 17, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01, 9.01 · filed Oct 6, 2025 · filing
  • Acquisition or disposal completed
    Form 8-K · items 1.01, 2.01, 9.01 · filed Sep 12, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2025
    Form 10-Q · filed Aug 14, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Aug 14, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Jul 3, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed May 15, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 15, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 8.01, 9.01 · filed Apr 18, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Mar 31, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2024
    Form 10-K · filed Mar 31, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01, 9.01 · filed Mar 28, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Feb 7, 2025 · filing
  • IPO prospectus (424B4): Final prospectus (424B4)
    Form 424B4 · filed Dec 31, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Dec 20, 2024 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Nov 22, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 14, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2024
    Form 10-Q · filed Nov 14, 2024 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Sep 27, 2024 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SC 13D · filed Sep 23, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.03, 5.07, 5.08, 9.01 · filed Sep 17, 2024 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Aug 23, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2024
    Form 10-Q · filed Aug 15, 2024 · filing
  • Late quarterly report notice: Quarterly report (10-Q) will be late
    Form NT 10-Q · filed Aug 15, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 15, 2024 · filing
  • Change of auditor
    Form 8-K · items 4.01, 9.01 · filed Jul 19, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Jun 21, 2024 · filing
  • Change of auditor
    Form 8-K · items 4.01, 9.01 · filed May 22, 2024 · filing
  • Results announced
    Form 8-K · items 2.02 · filed May 16, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2024
    Form 10-Q · filed May 15, 2024 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Apr 16, 2024 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SC 13D · filed Apr 8, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 2.01, 3.02, 3.03, 5.02, 5.03, 7.01, 9.01 · filed Apr 4, 2024 · filing
  • Acquisition or disposal completed
    Form 8-K · items 1.01, 2.01, 3.02, 3.03, 5.02, 5.03, 7.01, 9.01 · filed Apr 4, 2024 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2023
    Form 10-K · filed Apr 1, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 14, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2023
    Form 10-Q · filed Nov 14, 2023 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Sep 29, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2023
    Form 10-Q · filed Aug 14, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 10, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 15, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2023
    Form 10-Q · filed May 15, 2023 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2022
    Form 10-K · filed Mar 30, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 16, 2023 · filing